Back

Omecamtiv mecarbil

29 April 2017 (15:21 - 15:39)
Organised by:
Congress Presentation Part of: Novel drugs in acute heart failure: hurdles, hype and hope Acute heart failure (therapy) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor John R Teerlink

San Francisco Veterans Affairs Medical Centre, San Francisco (United States of America)

4 More presentations in this session

Presentation thumbnail
Serelaxin.
Professor M. Metra (Milan, IT)
Slides Video
Presentation thumbnail
HNO Donors.
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
Elamipretide.
Professor H. Sabbah (Detroit, US)
Slides Video
Presentation thumbnail
Vericiquat.
Professor B. Pieske (Rostock, DE)
Slides Video

Access the full session

Session thumbnail
Novel drugs in acute heart failure: hurdles, hype and hope

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 15:21 CET
You may be interested in
thumbnail
Congress Presentation
Omecamtiv mecarbil
20 May 2023
thumbnail
Congress Presentation
Biomechanical response of myosin modulator mavacamten in ultrathin slices of hypertrophic cardiomyopathy
20 May 2023
thumbnail
Congress Presentation
Cardiac biomarkers and cardiovascular side effects are associated with a reduced mortality of oncological patients receiving BRAF/MEK-Inhibitor therapy
21 June 2025
thumbnail
Congress Presentation
Mavacamten improves symptoms of shortness of breath in patients with obstructive hypertrophic cardiomyopathy (HCM): analysis of the HCM Symptom Questionnaire in the phase 3 EXPLORER trial
30 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources